Developments in Hodgkin lymphoma, CLL, multiple myeloma and follicular lymphoma
Myeloma 2017 day 2 highlights: MRD, targeted therapies and imaging advances
Gareth Morgan et al.
Improving existing imaging technology for multiple myeloma
The exciting field of imaging in multiple myeloma
Jens Hillengass et al.
The future of lymphoma treatment – combining new therapies with molecular diagnosis